|
DYNLL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.43689570931383E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.55191440096314E-15 |
| Normal-vs-Stage2 |
8.383600E-04 |
| Normal-vs-Stage3 |
1.58269999994687E-07 |
| Normal-vs-Stage4 |
1.16020004714557E-09 |
| Stage1-vs-Stage2 |
6.074200E-01 |
| Stage1-vs-Stage3 |
8.867400E-01 |
| Stage1-vs-Stage4 |
2.366200E-01 |
| Stage2-vs-Stage3 |
5.983400E-01 |
| Stage2-vs-Stage4 |
2.007000E-01 |
| Stage3-vs-Stage4 |
2.694200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.35207425653061E-14 |
| Normal-vs-AfricanAmerican |
4.08129086082454E-12 |
| Normal-vs-Asian |
1.200840E-01 |
| Caucasian-vs-AfricanAmerican |
2.710200E-01 |
| Caucasian-vs-Asian |
9.210600E-01 |
| AfricanAmerican-vs-Asian |
6.230600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
4.94819999974361E-07 |
| Male-vs-Female |
4.412000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.86879964228604E-10 |
| Normal-vs-Extreme_Weight |
6.66133814775094E-16 |
| Normal-vs-Obese |
6.91010026976357E-10 |
| Normal-vs-Extreme_Obese |
5.054100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.711000E-01 |
| Normal_Weight-vs-Obese |
2.645000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.702400E-01 |
| Extreme_Weight-vs-Obese |
1.495820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.407200E-01 |
| Obese-vs-Extreme_Obese |
7.525600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.620600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.54543045027822E-13 |
| Normal-vs-Age(61-80Yrs) |
1.72584169177981E-12 |
| Normal-vs-Age(81-100Yrs) |
9.97040000000338E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.690600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.911600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.748000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.914200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.273400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.448000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63269398001376E-12 |
| Normal-VS-Type2 PRCC |
8.44009995226713E-09 |
| Normal-VS-KIRP CIMP |
1.82090000000468E-06 |
| Normal-VS-Unclassified PRCC |
5.52459999999533E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.018400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.233800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.232400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.235200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.051000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.517600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06940012400969E-10 |
| Normal-vs-N1 |
5.12770048644029E-10 |
| Normal-vs-N2 |
5.708400E-02 |
| N0-vs-N1 |
9.878600E-01 |
| N0-vs-N2 |
5.638400E-01 |
| N1-vs-N2 |
4.804400E-01 |
|
|
